Explore more publications!
 Formation of Strategic Services JV Company and Investment by JV Partner
Lucinity Achieves Microsoft Certified Software for Financial AI
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
Costco Wholesale Corporation Reports September Sales Results
Correction - Exploration Update for Strategic Minerals JV
Amaroq Minerals Comments on Recent Trading Activity
Amaroq Files Technical Report for its Nalunaq Property
Oculis Reports Q2 2025 Financial Results and Provides Company Update
Annual Report and Notice of Meeting
Century Aluminum Signs Power Agreement Extension with Santee Cooper Through 2031
2024 Exploration Update for Strategic Minerals JV
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada
Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025
Update on Market Making Arrangements
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
Lucinity and PwC Collaborate to Simplify AI Integration for Compliance Teams
CLEAR+ Enrollment Now Available to More International Travelers for Seamless Airport Journeys
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions